Variables | n-CEA (n = 20) | DCEAS (n = 23) | P valueb |
---|---|---|---|
Female, n (%) | 13 (65.0) | 14 (60.9) | 0.780 |
Age (y)a | 66.5 ± 11.9 | 66.7 ± 13.6 | 0.969 |
Having previous stroke, n (%) | 2 (10.0) | 6 (26.1) | 0.250 |
Post-stroke duration (m)a | 10.2 ± 14.9 | 7.7 ± 11.6 | 0.547 |
Duration of PSD onset (m)a | 4.9 ± 12.0 | 4.7 ± 10.7 | 0.953 |
Having antidepressant treatment at study entry, n (%)c | 0.222 | ||
Fluoxetine (FLX) | 14 (70.0) | 15 (65.2) | |
Other antidepressant agentsd | 5 (25.0) | 3 (13.0) | |
Previous acupuncture experience, n (%) | 14 (70.0) | 13 (56.5) | 0.362 |
Baseline MMSEa | 23.5 ± 4.4 | 24.8 ± 4.8 | 0.354 |
Baseline HAMD-17a | 28.1 ± 7.0 | 25.8 ± 5.0 | 0.225 |
Baseline CGI-Sa | 4.8 ± 0.8 | 4.9 ± 0.5 | 0.580 |
Baseline BIa | 37.8 ± 10.7 | 37.7 ± 11.3 | 0.975 |